Coenzyme Q10 levels in maternal plasma and cord blood:: Correlations with mode of delivery

被引:15
|
作者
Compagnoni, G
Lista, G
Giuffrè, B
Mosca, F
Marini, A
机构
[1] ICP, Dept Neonatol, Milan, Italy
[2] Univ Milan, Inst Pediat & Neonatol, Milan, Italy
来源
BIOLOGY OF THE NEONATE | 2004年 / 86卷 / 02期
关键词
coenzyme Q(10); oxygen; Neonate; vaginal delivery; caesarean section; spinal anaesthesia; general anaesthesia;
D O I
10.1159/000078382
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Oxygen (O-2) plays a critical role in the O-2-reduction reactions indispensable for life, but can produce free radicals that are involved in many diseases. Coenzyme Q(10) (CoQ(10)), acting as a redox carrier in the respiratory chain, occupies a central position in the energy metabolism and oxidative defence. Neonates seem to be very subjected to oxidative stress because of their deficient antioxidant systems. Design/Methods: The aim of the study was to verify whether the mode of delivery may affect CoQ10 levels in the mother and neonate, and thus influence the risk of oxidative damage in the newborn. We measured CoQ10 levels in maternal plasma and cord blood at birth after three different modes of delivery (45 term healthy pregnancies): (1) vaginal in room air (VD) (n = 15); (2) elective caesarean section with general anaesthesia (50% O-2 and 50% N2O) (CSg) (n = 15), and (3) elective caesarean section with spinal anaesthesia without O-2 (CSs) (n = 15). Our results showed higher levels of Q(10) in mothers and neonates with VD (1.29 +/- 0.43 and 0.15 +/- 0.06 mug/ml, respectively) or CSs (1.15 +/- 0.28 and 0.24 +/- 0.06 mug/ml, respectively) when compared to CSg (0.74 +/- 0.28 and 0.07 +/- 0.03 mug/ml, respectively) (p < 0.01). Conclusions: These data demonstrate that the mode of delivery may affect CoQ(10) levels in mothers and neonates, and thus influence the risk of oxidative damage in the newborn. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:104 / 107
页数:4
相关论文
共 50 条
  • [41] Coenzyme Q10
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1229): : 19 - 20
  • [42] Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency
    Montini, Giovanni
    Malaventura, Cristina
    Salviati, Leonardo
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (26): : 2849 - 2850
  • [43] Oral coenzyme Q10 augments human myocardial post-hypoxic function and coenzyme Q10 levels
    Pepe, S
    Lyon, W
    Marasco, S
    Wowk, M
    Sheeran, F
    Ou, R
    Pick, A
    Smith, J
    Davis, B
    Esmore, D
    Nagley, P
    Rosenfeldt, F
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (06) : A92 - A92
  • [44] Effects of coenzyme Q10 and α-tocopherol administration on their tissue levels in the mouse:: Elevation of mitochondrial α-tocopherol by coenzyme Q10
    Lass, A
    Forster, MJ
    Sohal, RS
    FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (11-12) : 1375 - 1382
  • [46] Plasma membrane coenzyme Q10 and growth control
    Gómez-Díaz, C
    Barroso, MP
    Navas, P
    PROTOPLASMA, 2000, 214 (1-2) : 19 - 23
  • [47] Plasma membrane coenzyme Q10 and growth control
    C. Gómez-Díaz
    M. P. Barroso
    P. Navas
    Protoplasma, 2000, 214 : 19 - 23
  • [48] Efficiency of coenzyme Q10 at experimental spinal cord injury
    Kerimoglu, Alaeddin
    Pasaoglu, Oezguel
    Kanbak, Guengoer
    Hanci, Volkan
    Oezdemir, Filiz
    Atasoy, Metin Ant
    ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, 2007, 13 (02): : 85 - 93
  • [49] Effects of Coenzyme Q10 on Blood Biochemistry in Rats
    Kismali, Goerkem
    KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI, 2009, 15 (02) : 191 - 194
  • [50] Determination of coenzyme Q10 status in blood mononuclear cells, skeletal muscle, and plasma by HPLC with Di-propoxy-coenzyme Q10 as an internal standard
    Duncan, AJ
    Heales, SJR
    Mills, K
    Eaton, S
    Land, JM
    Hargreaves, IP
    CLINICAL CHEMISTRY, 2005, 51 (12) : 2380 - 2382